The promyelocytic leukemia protein protects p53 from Mdm2-mediated inhibition and degradation

被引:104
|
作者
Louria-Hayon, I
Grossman, T
Sionov, RV
Alsheich, O
Pandolfi, PP
Haupt, Y [1 ]
机构
[1] Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, IL-91120 Jerusalem, Israel
[2] Mem Sloan Kettering Canc Ctr, Dept Human Genet, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA
关键词
D O I
10.1074/jbc.M301264200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The p53 protein is kept labile under normal conditions. This regulation is governed largely by its major negative regulator, Mdm2. In response to stress however, p53 accumulates and becomes activated. For this to occur, the inhibitory effects of Mdm2 have to be neutralized. Here we investigated the role of the promyelocytic leukemia protein (PML) in the activation of p53 in response to stress. We found that PML is critical for the accumulation of p53 in response to DNA damage under physiological conditions. PML protects p53 from Mdm2-mediated ubiquitination and degradation, and from inhibition of apoptosis. PML neutralizes the inhibitory effects of Mdm2 by prolonging the stress-induced phosphorylation of p53 on serine 20, a site of the checkpoint kinase 2 (Chk2). PML recruits Chk2 and p53 into the PML nuclear bodies and enhances p53/Chk2 interaction. Our results provide a novel mechanistic explanation for the cooperation between PML and p53 in response to DNA damage.
引用
收藏
页码:33134 / 33141
页数:8
相关论文
共 50 条
  • [1] MdmX protects p53 from Mdm2-mediated degradation
    Jackson, MW
    Berberich, SJ
    MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (03) : 1001 - 1007
  • [2] Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5
    Dai, MS
    Lu, H
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (43) : 44475 - 44482
  • [3] Cocompartmentalization of p53 and Mdm2 is a major determinant for Mdm2-mediated degradation of p53
    Xirodimas, DP
    Stephen, CW
    Lane, DP
    EXPERIMENTAL CELL RESEARCH, 2001, 270 (01) : 66 - 77
  • [4] Akt enhances Mdm2-mediated ubiquitination and degradation of p53
    Ogawara, Y
    Kishishita, S
    Obata, T
    Isazawa, Y
    Suzuki, T
    Tanaka, K
    Masuyama, N
    Gotoh, Y
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (24) : 21843 - 21850
  • [5] Cytoplasmically "sequestered" wild type p53 protein is resistant to Mdm2-mediated degradation
    Zaika, A
    Marchenko, N
    Moll, UM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (39) : 27474 - 27480
  • [6] Mdm2-mediated ubiquitylation: p53 and beyond
    Marine, J-C
    Lozano, G.
    CELL DEATH AND DIFFERENTIATION, 2010, 17 (01): : 93 - 102
  • [7] XPC promotes MDM2-mediated degradation of the p53 tumor suppressor
    Krzeszinski, Jing Yan
    Choe, Vitnary
    Shao, Jia
    Bao, Xin
    Cheng, Haili
    Luo, Shiwen
    Huo, Keke
    Rao, Hai
    MOLECULAR BIOLOGY OF THE CELL, 2014, 25 (02) : 213 - 221
  • [8] Mdm2-mediated ubiquitylation: p53 and beyond
    J-C Marine
    G Lozano
    Cell Death & Differentiation, 2010, 17 : 93 - 102
  • [9] p300/MDM2 complexes participate in MDM2-mediated p53 degradation
    Grossman, SR
    Perez, M
    Kung, AL
    Joseph, M
    Mansur, C
    Xiao, ZX
    Kumar, S
    Howley, PM
    Livingston, DM
    MOLECULAR CELL, 1998, 2 (04) : 405 - 415
  • [10] TRIAD1 inhibits MDM2-mediated p53 ubiquitination and degradation
    Bae, Seunghee
    Jung, Jin Hyuk
    Kim, Karam
    An, In-Sook
    Kim, Soo-Yeon
    Lee, Jae Ho
    Park, In-Chul
    Jin, Young-Woo
    Lee, Su-Jae
    An, Sungkwan
    FEBS LETTERS, 2012, 586 (19) : 3057 - 3063